Trials / Completed
CompletedNCT04314557
Renal Arterial Denervation in Sympathetic Dysautonomia
Renal Arterial Denervation in Sympathetic Dysautonomia: RANSOM REGISTRY
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13 (actual)
- Sponsor
- St Carlos Hospital, Madrid, Spain · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The RANSOM registry is considered as a collection of data with the ultimate purpose of gathering information about the effect of renal denervation in patients of the investigator's center and evaluating the results within the usual clinical practice. The general objective of the study is to evaluate the clinical results (blood pressure, quality of life and levels of catecholamines) as well as safety of renal sympathetic denervation in hypertensive patients, at least in treatment with an antihypertensive drug and with increased variability, considering as such a standard deviation\> 10 mmHg for systolic BP and\> 5 for diastolic BP of its blood pressure levels, measured by ABPM.
Conditions
- Hypertension
- Renal Denervation
- Increased Variability
- Blood Pressure Disorders
- Blood Pressure Variability
- Sympathetic Dysautonomia
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Renal denervation | Spyral device. Bilateral renal denervation. |
Timeline
- Start date
- 2019-03-14
- Primary completion
- 2025-05-31
- Completion
- 2025-05-31
- First posted
- 2020-03-19
- Last updated
- 2025-07-30
Locations
1 site across 1 country: Spain
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04314557. Inclusion in this directory is not an endorsement.